In what it says could be the largest disclosed patent settlement in the pharmaceutical industry, Roivant Sciences has reached a potential $2.25 billion settlement with Moderna Inc. over the use of its lipid nanoparticle (LNP) delivery technology in the Sp... See more
Pfizer Inc. is threatening legal action at an attempt by Novo Nordisk A/S is to scupper its acquisition of Metsera Inc ., with an unsolicited $9 billion offer for the anti-obesity specialist.
That trumps Pfizer’s agreed bid made in September, which valued... See more
Nephrology Climb Bio reports NHP data with CLYM-116 Sep. 30, 2025 No Comments Climb Bio Inc. has announced results from a completed nonhuman primate (NHP) study of CLYM-116, an anti-APRIL monoclonal antibody (mAb) in development for IgA nephropathy. Read ... See more
Dermatologic GS-6791 shows promise in murine dermatitis model Sep. 30, 2025 No Comments Interleukin-1 receptor-associated kinase 4 (IRAK-4) is a modulator of IL-1 receptor and Toll-like receptor (TLR) signaling and has emerged as a promising therapeutic t... See more
